XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Assets and Liabilities
The following tables present the classification within the fair value hierarchy of financial assets and liabilities not disclosed elsewhere in these Condensed Consolidated Financial Statements that are remeasured on a recurring basis as of March 31, 2023 and December 31, 2022. Other than the Company’s fixed-rate convertible debt disclosed in Note 6Debt, there were no financial assets or liabilities that were remeasured using a quoted price in active markets for identical assets (Level 1) as of March 31, 2023 or December 31, 2022.
Fair Value Measurements as of March 31, 2023
Significant Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
Other current assets:
NQDC Plan assets$1,948 $— $1,948 
Other assets:
NQDC Plan assets23,958 — 23,958 
Restricted investments (1)
2,366 — 2,366 
Total other assets26,324 — 26,324 
Total assets$28,272 $— $28,272 
Liabilities:
Current liabilities:
NQDC Plan liability$1,948 $— $1,948 
Other long-term liabilities:
NQDC Plan liability23,958 — 23,958 
Total liabilities$25,906 $— $25,906 
Fair Value Measurements as of December 31, 2022
Significant Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
Other current assets:
NQDC Plan assets$2,654 $— $2,654 
Other assets:
NQDC Plan assets19,867 — 19,867 
Restricted investments (1)
2,429 — 2,429 
Total other assets22,296 — 22,296 
Total assets$24,950 $— $24,950 
Liabilities:
Current liabilities:
NQDC Plan liability$2,654 $— $2,654 
Contingent consideration— 15,925 15,925 
Total current liabilities2,654 15,925 18,579 
Other long-term liabilities:
NQDC Plan liability19,867 — 19,867 
Total liabilities$22,521 $15,925 $38,446 
(1)    The restricted investments at March 31, 2023 and December 31, 2022 secure the Company's irrevocable standby letters of credit obtained in connection with certain commercial agreements.
Schedule of Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs
Liabilities measured at fair value using Level 3 inputs consisted of contingent consideration. The following table represents a roll-forward of contingent consideration.

Contingent consideration as of December 31, 2022$15,925 
Milestone payments to Ares Trading S.A. (Merck Serono)(16,255)
Realized foreign exchange loss on settlement of contingent consideration330 
Contingent consideration as of March 31, 2023$—